Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience

Claire Horgan; Shereef Elmoamly; Graham McIlroy; David Davies; Maria Kaparou; Hannah Giles; Evgenia Xenou; Bhuvan Kishore; Richard Lovell; Emmanouil Nikolousis; Paneesha Shankara; Alexandros Kanellopoulos

doi:10.1080/10428194.2019.1607323

Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience

Claire Horgan, Shereef Elmoamly, Graham McIlroy, David Davies, Maria Kaparou, Hannah Giles, Evgenia Xenou, Bhuvan Kishore, Richard Lovell, Emmanouil Nikolousis, Paneesha Shankara, Alexandros Kanellopoulos^*

^*Corresponding author for this work

Immunology and Immunotherapy

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3075-3077
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	60
Issue number	12
DOIs	https://doi.org/10.1080/10428194.2019.1607323
Publication status	Published - 15 Oct 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2019.1607323

Cite this

Horgan, C., Elmoamly, S., McIlroy, G., Davies, D., Kaparou, M., Giles, H., Xenou, E., Kishore, B., Lovell, R., Nikolousis, E., Shankara, P., & Kanellopoulos, A. (2019). Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience. Leukemia and Lymphoma, 60(12), 3075-3077. https://doi.org/10.1080/10428194.2019.1607323

@article{d16ce13db3134b52a34a65ce7620e86e,

title = "Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience",

author = "Claire Horgan and Shereef Elmoamly and Graham McIlroy and David Davies and Maria Kaparou and Hannah Giles and Evgenia Xenou and Bhuvan Kishore and Richard Lovell and Emmanouil Nikolousis and Paneesha Shankara and Alexandros Kanellopoulos",

year = "2019",

month = oct,

day = "15",

doi = "10.1080/10428194.2019.1607323",

language = "English",

volume = "60",

pages = "3075--3077",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "12",

}

Horgan, C, Elmoamly, S, McIlroy, G, Davies, D, Kaparou, M, Giles, H, Xenou, E, Kishore, B, Lovell, R, Nikolousis, E, Shankara, P & Kanellopoulos, A 2019, 'Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience', Leukemia and Lymphoma, vol. 60, no. 12, pp. 3075-3077. https://doi.org/10.1080/10428194.2019.1607323

TY - JOUR

T1 - Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma

T2 - reflections on a single center experience

AU - Horgan, Claire

AU - Elmoamly, Shereef

AU - McIlroy, Graham

AU - Davies, David

AU - Kaparou, Maria

AU - Giles, Hannah

AU - Xenou, Evgenia

AU - Kishore, Bhuvan

AU - Lovell, Richard

AU - Nikolousis, Emmanouil

AU - Shankara, Paneesha

AU - Kanellopoulos, Alexandros

PY - 2019/10/15

Y1 - 2019/10/15

UR - http://www.scopus.com/inward/record.url?scp=85065732111&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1607323

DO - 10.1080/10428194.2019.1607323

M3 - Letter

C2 - 31079514

AN - SCOPUS:85065732111

SN - 1042-8194

VL - 60

SP - 3075

EP - 3077

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -